223 related articles for article (PubMed ID: 31710339)
1. Association of Testosterone Therapy With Risk of Venous Thromboembolism Among Men With and Without Hypogonadism.
Walker RF; Zakai NA; MacLehose RF; Cowan LT; Adam TJ; Alonso A; Lutsey PL
JAMA Intern Med; 2020 Feb; 180(2):190-197. PubMed ID: 31710339
[TBL] [Abstract][Full Text] [Related]
2. Risk of Venous Thromboembolism in Men Receiving Testosterone Therapy.
Baillargeon J; Urban RJ; Morgentaler A; Glueck CJ; Baillargeon G; Sharma G; Kuo YF
Mayo Clin Proc; 2015 Aug; 90(8):1038-45. PubMed ID: 26205547
[TBL] [Abstract][Full Text] [Related]
3. Testosterone therapy and venous thromboembolism: A systematic review and meta-analysis.
Houghton DE; Alsawas M; Barrioneuvo P; Tello M; Farah W; Beuschel B; Prokop LJ; Layton JB; Murad MH; Moll S
Thromb Res; 2018 Dec; 172():94-103. PubMed ID: 30396049
[TBL] [Abstract][Full Text] [Related]
4. Association between Use of Exogenous Testosterone Therapy and Risk of Venous Thrombotic Events among Exogenous Testosterone Treated and Untreated Men with Hypogonadism.
Li H; Benoit K; Wang W; Motsko S
J Urol; 2016 Apr; 195(4 Pt 1):1065-72. PubMed ID: 26523880
[TBL] [Abstract][Full Text] [Related]
5. Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy.
Ory J; Nackeeran S; Balaji NC; Hare JM; Ramasamy AR
J Urol; 2022 Jun; 207(6):1295-1301. PubMed ID: 35050717
[TBL] [Abstract][Full Text] [Related]
6. Statin Use and the Risk of Venous Thromboembolism in Women Taking Hormone Therapy.
Davis JW; Weller SC; Porterfield L; Chen L; Wilkinson GS
JAMA Netw Open; 2023 Dec; 6(12):e2348213. PubMed ID: 38100102
[TBL] [Abstract][Full Text] [Related]
7. Topical Testosterone Therapy Adherence and Outcomes Among Men With Primary or Secondary Hypogonadism.
Grabner M; Hepp Z; Raval A; Tian F; Khera M
J Sex Med; 2018 Feb; 15(2):148-158. PubMed ID: 29425664
[TBL] [Abstract][Full Text] [Related]
8. Bevacizumab Use and the Risk of Arterial and Venous Thromboembolism in Patients with High-Grade Gliomas: A Nested Case-Control Study.
Lee I; Adimadhyam S; Nutescu EA; Zhou J; Asfaw AA; Sweiss KI; Patel PR; Calip GS
Pharmacotherapy; 2019 Sep; 39(9):921-928. PubMed ID: 31332810
[TBL] [Abstract][Full Text] [Related]
9. Testosterone Therapy and Risk of Acute Myocardial Infarction in Hypogonadal Men: An Administrative Health Care Claims Study.
Li H; Mitchell L; Zhang X; Heiselman D; Motsko S
J Sex Med; 2017 Nov; 14(11):1307-1317. PubMed ID: 29110802
[TBL] [Abstract][Full Text] [Related]
10. Testosterone treatment is not associated with increased risk of adverse cardiovascular events: results from the Registry of Hypogonadism in Men (RHYME).
Maggi M; Wu FC; Jones TH; Jackson G; Behre HM; Hackett G; Martin-Morales A; Balercia G; Dobs AS; Arver ST; Maggio M; Cunningham GR; Isidori AM; Quinton R; Wheaton OA; Siami FS; Rosen RC;
Int J Clin Pract; 2016 Oct; 70(10):843-852. PubMed ID: 27774779
[TBL] [Abstract][Full Text] [Related]
11. Testosterone treatment and risk of venous thromboembolism: population based case-control study.
Martinez C; Suissa S; Rietbrock S; Katholing A; Freedman B; Cohen AT; Handelsman DJ
BMJ; 2016 Nov; 355():i5968. PubMed ID: 27903495
[TBL] [Abstract][Full Text] [Related]
12. Testosterone Therapy Raises Risk of Venous Thromboembolism.
Rosenberg K
Am J Nurs; 2020 Apr; 120(4):50. PubMed ID: 32218050
[No Abstract] [Full Text] [Related]
13. Efficacy of Testosterone Replacement Therapy in Correcting Anemia in Men With Hypogonadism: A Randomized Clinical Trial.
Pencina KM; Travison TG; Artz AS; Lincoff AM; Nissen SE; Flevaris P; Chan A; Li X; Diegel SA; Wannemuehler K; Bhasin S
JAMA Netw Open; 2023 Oct; 6(10):e2340030. PubMed ID: 37889486
[TBL] [Abstract][Full Text] [Related]
14. Optimal diagnostic measures and thresholds for hypogonadism in men with HIV/AIDS: comparison between 2 transdermal testosterone replacement therapy gels.
Blick G
Postgrad Med; 2013 Mar; 125(2):30-9. PubMed ID: 23816769
[TBL] [Abstract][Full Text] [Related]
15. Risk of Venous Thromboembolism in Patients With Keratinocyte Carcinoma.
Rudy SF; Li K; Moubayed SP; Most SP
JAMA Facial Plast Surg; 2018 Dec; 20(6):453-459. PubMed ID: 29800029
[TBL] [Abstract][Full Text] [Related]
16. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
Blick G; Khera M; Bhattacharya RK; Kushner H; Miner MM
Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
[TBL] [Abstract][Full Text] [Related]
17. Effects of 8-Year Treatment of Long-Acting Testosterone Undecanoate on Metabolic Parameters, Urinary Symptoms, Bone Mineral Density, and Sexual Function in Men With Late-Onset Hypogonadism.
Permpongkosol S; Khupulsup K; Leelaphiwat S; Pavavattananusorn S; Thongpradit S; Petchthong T
J Sex Med; 2016 Aug; 13(8):1199-211. PubMed ID: 27436076
[TBL] [Abstract][Full Text] [Related]
18. Venous thromboembolism after trauma: when do children become adults?
Van Arendonk KJ; Schneider EB; Haider AH; Colombani PM; Stewart FD; Haut ER
JAMA Surg; 2013 Dec; 148(12):1123-30. PubMed ID: 24173244
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: the Tromso study.
Svartberg J; Braekkan SK; Laughlin GA; Hansen JB
Eur J Endocrinol; 2009 May; 160(5):833-8. PubMed ID: 19208774
[TBL] [Abstract][Full Text] [Related]
20. Association of Male Hypogonadism With Risk of Hospitalization for COVID-19.
Dhindsa S; Champion C; Deol E; Lui M; Campbell R; Newman J; Yeggalam A; Nadella S; Ahir V; Shrestha E; Kannampallil T; Diwan A
JAMA Netw Open; 2022 Sep; 5(9):e2229747. PubMed ID: 36053534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
